The DOI matches its Crossref record; 516 of the 516 references it cites were found in a registry or an index.
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Open accessAbstract
The immune system is a very diverse system of the host that evolved during evolution to cope with various pathogens present in the vicinity of environmental surroundings inhabited by multicellular organisms ranging from achordates to chordates (including humans). For example, cells of immune system express various pattern recognition receptors (PRRs) that detect danger via recognizing specific pathogen-associated molecular patterns (PAMPs) and mount a specific immune response. Toll-like receptors (TLRs) are one of these PRRs expressed by various immune cells. However, they were first discovered in the Drosophila melanogaster (common fruit fly) as genes/proteins important in embryonic development and dorso-ventral body patterning/polarity. Till date, 13 different types of TLRs (TLR1-TLR13) have been discovered and described in mammals since the first discovery of TLR4 in humans in late 1997. This discovery of TLR4 in humans revolutionized the field of innate immunity and thus the immunology and host-pathogen interaction. Since then TLRs are found to be expressed on various immune cells and have been targeted for therapeutic drug development for various infectious and inflammatory diseases including cancer. Even, Single nucleotide polymorphisms (SNPs) among various TLR genes have been identified among the different human population and their association with susceptibility/resistance to certain infections and other inflammatory diseases. Thus, in the present review the current and future importance of TLRs in immunity, their pattern of expression among various immune cells along with TLR based therapeutic approach is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–516 of 516
Natural killer cells in human pregnancy
Vacca, P., Mingari, M. C., & Moretta, L. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.10.008 · Cited by 78
Dietrich, N. L., Rohde, M., Geffers, R., Kröger, A., Häuser, H., Weiß, S., & Gekara, N. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912551107 · Cited by 78
Inflammation and neurodegeneration: the story ‘retolled’
Drouin‐Ouellet, J., & Cicchetti, F. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.07.002 · Cited by 78
Toll-like receptors in acute liver injury and regeneration
Chen, Y., & Sun, R. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.04.023 · Cited by 77
Biswas, S., Zimman, A., Gao, D., Byzova, T. V., & Podrez, E. A. (2017) · Circulation Research · doi:10.1161/circresaha.117.311069 · Cited by 77
Septic Mice Are Susceptible to Pulmonary Aspergillosis
Benjamim, C. F., Hogaboam, C. M., Lukacs, N. W., & Kunkel, S. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63615-2 · Cited by 76
Marafini, I., Monteleone, I., Fusco, D. D., Cupi, M. L., Paoluzi, O. A., Colantoni, A., Ortenzi, A., Izzo, R., Vita, S., Luca, E. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126291 · Cited by 75
Myeloid-derived suppressor cells control microbial sepsis
Derive, M., Bouazza, Y., Alauzet, C., & Gibot, S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2574-4 · Cited by 75
Deetz, C. O., Hebbeler, A. M., Propp, N., Cairo, C., Tikhonov, I. I., & Pauza, C. D. (2006) · Infection and Immunity · doi:10.1128/iai.00088-06 · Cited by 75
Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2
Yoshioka, M., Fukuishi, N., Iriguchi, S., Ohsaki, K., Yamanobe, H., Inukai, A., Kurihara, D., Imajo, N., Yasui, Y., Matsui, N., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.027 · Cited by 74
Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers
North, S. A., & Butts, C. A. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.3.249 · Cited by 74
Emerging Evidence for Platelets as Immune and Inflammatory Effector Cells
Rondina, M. T., & Garraud, O. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00653 · Cited by 72
Gammadelta T Cells in Crohn’s Disease: A New Player in the Disease Pathogenesis?
Catalán‐Serra, I., Sandvik, A. K., Bruland, T., & Andreu‐Ballester, J. C. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx039 · Cited by 71
Markwart, R., Condotta, S. A., Requardt, R. P., Borken, F., Schubert, K., Weigel, C., Bauer, M. W., Griffith, T. S., Förster, M., Brunkhorst, F. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115094 · Cited by 70
Association of the Polymorphism for Toll‐like Receptor 2 with Type 1 Diabetes Susceptibility
Park, Y., Park, S.-K., Yoo, E., Kim, D., & SHIN, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1337.028 · Cited by 69
Alterations of Dendritic Cells in Sepsis: Featured Role in Immunoparalysis
Fan, X., Liu, Z., Jin, H., Yan, J., & Liang, H.-P. (2015) · BioMed Research International · doi:10.1155/2015/903720 · Cited by 67
Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection
Badgwell, B. D., Parihar, R., MAGRO, C. M. J., Dierksheide, J. E., Russo, T. A., & Carson, W. E. (2002) · Surgery · doi:10.1067/msy.2002.125311 · Cited by 67
Polymorphisms of the Toll-Like Receptors and Human Disease
Sutherland, A. M., & Cook, D. N. (2005) · Clinical Infectious Diseases · doi:10.1086/431985 · Cited by 67
Geller, M. A., Cooley, S., Argenta, P. A., Downs, L. S., Carson, L. F., Judson, P. L., Ghebre, R. G., Weigel, B. J., Panoskaltsis‐Mortari, A., Curtsinger, J., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0914-1 · Cited by 67
Toll-like receptor 9 antagonizes antibody affinity maturation
Akkaya, M., Akkaya, B., Kim, A. S., Miozzo, P., Sohn, H., Pena, M., Roesler, A. S., Theall, B. P., Henke, T., Kabat, J., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0052-z · Cited by 66
Al-Qahtani, A. A., Al‐Ahdal, M. N., Abdo, A. A., Sanai, F. M., Al‐Anazi, M. R., Khalaf, N. Z., Viswan, N. A., Al-Ashgar, H. I., Alhumaidan, H., Al‐Suwayeh, R., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23271 · Cited by 66
Tadema, H., Abdulahad, W. H., Stegeman, C. A., Kallenberg, C. G. M., & Heeringa, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024315 · Cited by 66
Origin of Toll-Like Receptor-Mediated Innate Immunity
Kanzok, S. M., Hoa, N. T., Bonizzoni, M., Luna, C., Huang, Y., Malacrida, A. R., & Zheng, L. (2004) · Journal of Molecular Evolution · doi:10.1007/s00239-003-2565-8 · Cited by 65
Innate lymphoid cells: New paradigm in immunology of inflammation
Kumar, V. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.003 · Cited by 64
Ranta, V., Orpana, A., Carpén, O., Turpeinen, U., Ylikorkala, O., & Viinikka, L. U. (1999) · Critical Care Medicine · doi:10.1097/00003246-199910000-00019 · Cited by 64
Wilhelmsen, K., Mesa, K. R., Prakash, A., Xu, F., & Hellman, J. (2011) · Innate Immunity · doi:10.1177/1753425911429336 · Cited by 64
Alejandra Trejo-de la, O., Hernández-Sancén, P., & Maldonado‐Bernal, C. (2014) · Genes and Immunity · doi:10.1038/gene.2014.10 · Cited by 64
Tomita, T., Kanai∥, T., Fujii, T., Nemoto, Y., Okamoto, R., Tsuchiya, K., Totsuka, T., Sakamoto, N., Akira, S., & Watanabe, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5291 · Cited by 64
γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration
Gelderblom, M., Arunachalam, P., & Magnus, T. U. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00368 · Cited by 60
TRAF5 Negatively Regulates TLR Signaling in B Lymphocytes
Buchta, C. M., & Bishop, G. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301901 · Cited by 60
TLR signalling and association of TLR polymorphism with cardiovascular diseases
Sharma, S., Garg, I., & Ashraf, M. Z. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.10.008 · Cited by 60
CD36 Is Differentially Expressed on B Cell Subsets during Development and in Responses to Antigen
Won, W.-J., Bachmann, M. F., & Kearney, J. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.230 · Cited by 59
Huang, S., Kao, J., Wu, C., Wang, S.-T., Lee, H., Liang, S., Chen, Y., & Shieh, J. (2014) · Oncotarget · doi:10.18632/oncotarget.1734 · Cited by 59
T-Cell-Mediated Immunity and the Role of TRAIL in Sepsis-Induced Immunosuppression
Condotta, S. A., Cabrera-Pérez, J., Badovinac, V. P., & Griffith, T. S. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006721 · Cited by 59
Sun, J., Wiklund, F. E., Hsu, F., Bälter, K. A., Zheng, S., Johansson, J., Chang, B., Liu, W., Li, T., Turner, A. R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0645 · Cited by 59
Neuroinflammation in Sepsis: Sepsis Associated Delirium
Piva, S., McCreadie, V., & Latronico, N. (2015) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x15666150108112452 · Cited by 59
Evolution of natural killer cell receptors
Mager, D. L., McQueen, K. L., Wee, V., & Freeman, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00148-8 · Cited by 56
γδ T cells mitigate the organ injury and mortality of sepsis
Tschöp, J., Martignoni, A., Goetzman, H. S., Choi, L. G., Wang, Q., Noel, J. G., Ogle, C. K., Pritts, T. A., Johannigman, J. A., Lentsch, A. B., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0707507 · Cited by 56
Xu, H., Wang, X., Lackner, A. A., & Veazey, R. S. (2015) · The FASEB Journal · doi:10.1096/fj.15-276477 · Cited by 55
Li, G., Domenico, J. M., Jia, Y., Lucas, J. J., & Gelfand, E. W. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000218115 · Cited by 55
Toll signaling: the enigma variations
Wasserman, S. A. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00118-0 · Cited by 55
Tissue distribution of human gamma delta T cells: no evidence for general epithelial tropism.
Feltkamp‐Vroom, T. M., Scholte, G., OSSENDORP, F. A., & Borst, J. G. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.12.1012 · Cited by 54
Platelets in Atherosclerosis and Thrombosis
Schulz, C., & Maßberg, S. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_5 · Cited by 53
Defining the subcellular sites of innate immune signal transduction
Kagan, J. C. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.005 · Cited by 53
Modulation of B cell responses by Toll-like receptors
Booth, J. S., Wilson, H. L., Jimbo, S., & Mutwiri, G. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1031-3 · Cited by 52
Saikh, K. U., Lee, J. S., Kissner, T. L., Dyas, B. K., & Ulrich, R. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/379196 · Cited by 52
TLRs, NF- κ B, JNK, and Liver Regeneration
Iimuro, Y., & Fujimoto, J. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/598109 · Cited by 52
The role of natural killer cells in pathogenesis of autoimmune diseases
Popko, K., & Górska, E. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2015.56971 · Cited by 52
Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control
Baird, J. R., Monjazeb, A. M., Shah, O., McGee, H. M., Murphy, W. J., Crittenden, M. R., & Gough, M. J. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.04.014 · Cited by 52
The future of toll-like receptor therapeutics.
Parkinson, T. (2008) · PubMed · Cited by 51
Roelofs, M. F., Abdollahi‐Roodsaz, S., Joosten, L. A. B., van den Berg, W. B., & Radstake, T. R. D. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23217 · Cited by 51
Boyd, A., Ribeiro, J. M. C., & Nutman, T. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108649 · Cited by 50
Primitive Toll signalling: bugs, flies, worms and man
Fallon, P. G., Allen, R. L., & Rich, T. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01800-7 · Cited by 48
Cutting Edge: Intrinsic Programming of Thymic γδT Cells for Specific Peripheral Tissue Localization
Jin, Y., Xia, M., Saylor, C. M., Narayan, K., Kang, J., Wiest, D. L., Wang, Y., & Xiong, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002781 · Cited by 48
Hoffman, E. S., Smith, R. E. T., & Renaud, R. C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1880 · Cited by 48
Alcaide, M. L., Štrbo, N., Romero, L., Jones, D. L., Rodriguez, V. J., Arheart, K. L., Martínez, O., Bolívar, H., Podack, E. R., & Fischl, M. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153045 · Cited by 48
Svensson, A., Tunbäck, P., Nordström, I., Padyukov, L., & Eriksson, K. (2012) · Journal of General Virology · doi:10.1099/vir.0.042572-0 · Cited by 47
Chen, S., Wong, M. H., Schulte, D. J., Arditi, M., & Michelsen, K. S. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907085096 · Cited by 47
Mölne, L., Corthay, A., Holmdahl, R., & Tarkowski, A. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02151.x · Cited by 47
Neonatal Natural Killer Cell Function: Relevance to Antiviral Immune Defense
Lee, Y.-C., & Lin, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/427696 · Cited by 45
B cells as under-appreciated mediators of non-auto-immune inflammatory disease
Nikolajczyk, B. S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.022 · Cited by 44
KIZILTAŞ, Ş., Ata, P., Çolak, Y., Mesçi, B., Şenateş, E., Enc, F. Y., Ulaşoğlu, C., Tuncer, İ., & Oğuz, A. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0120 · Cited by 43
Wilhelmsen, K., Mesa, K. R., Lucero, J. M., Xu, F., & Hellman, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359489 · Cited by 43
Toliver-Kinsky, T. E., Lin, C. Y., Herndon, D. N., & Sherwood, E. R. (2003) · Infection and Immunity · doi:10.1128/iai.71.6.3058-3067.2003 · Cited by 43
Meena, N. K., Ahuja, V., Meena, K., & Paul, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120697 · Cited by 43
Toll-Like Receptors and Type 1 Diabetes
Zipris, D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_25 · Cited by 43
Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function
Karim, A. F., Reba, S. M., Li, Q., Boom, W. H., & Rojas, R. E. (2017) · European Journal of Immunology · doi:10.1002/eji.201646846 · Cited by 43
Absence of TRIF Signaling in Lipopolysaccharide-Stimulated Murine Mast Cells
Keck, S., Müller, I., Fejér, G., Savic, I., Tchaptchet, S., Nielsen, P. J., Galanos, C., Huber, M., & Freudenberg, M. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000458 · Cited by 41
de Stoppelaar, S. F., Claushuis, T. A. M., Schaap, M. C. L., Hou, B., van der Poll, T., Nieuwland, R., & Veer, C. V. ′. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156977 · Cited by 41
Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
Panter, G., Kužnik, A., & Jerala, R. (2009) · PubMed · Cited by 40
Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children
Studzińska, M., Jabłońska, A., Wiśniewska‐Ligier, M., Nowakowska, D., Gaj, Z., Lesnikowski, Z. J., Woźniakowska‐Gęsicka, T., Wilczyński, J., & Paradowska, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169420 · Cited by 40
Garrafa, E., Imberti, L., Tiberio, G. A. M., Prandini, A., Giulini, S. M., & Caimi, L. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.111 · Cited by 38
Mnich, S. J., Blanner, P. M., Hu, L. G., Shaffer, A. F., Happa, F. A., O’Neil, S. P., Ukairo, O. T., Weiss, D., Welsh, E. A., Storer, C. E., et al. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.023 · Cited by 38
Mitochondrial damage-associated molecular patterns activate γδ T-cells
Schwacha, M. G., Rani, M., Zhang, Q., Nunez-Cantu, O., & Cap, A. P. (2013) · Innate Immunity · doi:10.1177/1753425913488969 · Cited by 38
Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling
Maruyama, A., Shime, H., Takeda, Y., Azuma, M., Matsumoto, M., & Seya, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.011 · Cited by 37
Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game
Kumar, V., & Ahmad, A. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1380199 · Cited by 37
Activation of plasmacytoid dendritic cells
Fuchsberger, M., Hochrein, H., & O’Keeffe, M. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01392.x · Cited by 36
Ojeda, M. O., Veer, C. V. ′., Ortega, C. F., Rosaínz, M. D. J. A., & Buurman, W. A. (2005) · Inflammation Research · doi:10.1007/s00011-004-1326-5 · Cited by 36
Toll Like Receptors in systemic sclerosis: An emerging target
O’Reilly, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.09.001 · Cited by 36
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo
Patrignani, P., Febbo, C. D., Tacconelli, S., Moretta, V., Baccante, G., Sciulli, M. G., Ricciotti, E., Capone, M. L., Antonucci, I., Guglielmi, M. D., et al. (2006) · Blood · doi:10.1182/blood-2005-12-4811 · Cited by 35
Dendritic Cell Modification of Neutrophil Responses to Infection after Burn Injury
Bohannon, J. K., Cui, W., Sherwood, E. R., & Toliver-Kinsky, T. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903619 · Cited by 34
Innate Immunity in Sepsis Pathogenesis and Its Modulation: New Immunomodulatory Targets Revealed
Kumar, V., & Sharma, A. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.6.672 · Cited by 33
Role of microglia and toll-like receptor 4 in the pathophysiology of delirium
Jalleh, R. J., KOH, K. S. B., Choi, B., Liu, E., Maddison, J., & Hutchinson, M. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.013 · Cited by 31
γδ Cells and the Regulation of Mucosal Immune Responses
Hayday, A., Roberts, S. J., & Ramsburg, E. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac4 · Cited by 31
Myeloid-Derived Suppressor Cells in Sepsis
Lai, D., Qin, C., & Shu, Q. (2014) · BioMed Research International · doi:10.1155/2014/598654 · Cited by 31
Ma, L., Tang, F. Y., Chu, W. K., Young, A. L., Brelen, M. E., Pang, C. P., & Chen, L. J. (2016) · Scientific Reports · doi:10.1038/srep19718 · Cited by 29
Role of TLR4 Receptor Polymorphisms in Boutonneuse Fever
Balistreri, C. R., Candore, G., Lio, D., Colonna‐Romano, G., Lorenzo, G. D., Mansueto, P., Rini, G. B., Mansueto, S., Cillari, E., Franceschi, C., et al. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800406 · Cited by 28
Perego, J., Mendes, A. V., Bourbon, C., Camosseto, V., Combes, A. J., Liu, H., Manh, T. V., Dalet, A., Chasson, L., Spinelli, L., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aam8104 · Cited by 28
TLR3 gene polymorphisms in cancer: a systematic review and meta-analysis
Wang, B.-G., Yi, D., & Liu, Y. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0020-z · Cited by 27
Roquilly, A., Broquet, A. H., Jacqueline, C., Gautreau‐Rolland, L., Segain, J. P., de Coppet, P., Caillon, J., Altare, F., Josien, R., & Asehnoune, K. (2013) · European Respiratory Journal · doi:10.1183/09031936.00152612 · Cited by 27
Sivori, S., Falco, M., Moretta, L., & Moretta, A. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.007 · Cited by 26
Dermal γδ T-Cells Can Be Activated by Mitochondrial Damage-Associated Molecular Patterns
Schwacha, M. G., Rani, M., Nicholson, S. E., Lewis, A. M., Holloway, T. L., Sordo, S., & Cap, A. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158993 · Cited by 26
Targeting Toll-like receptors against cancer
Du, B., Jiang, Q., Cleveland, J. C., Liu, B., & Zhang, D. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.62 · Cited by 26
Genetic susceptibility to infections withAspergillus fumigatus
Mezger, M., Einsele, H., & Loeffler, J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903530619 · Cited by 23
Wifi, M.-N. A., Assem, M., Elsherif, R. H., El-Azab, H. A.-F., & Saif, A. (2017) · Medicine · doi:10.1097/md.0000000000006760 · Cited by 23
How regulatory T cells sense and adapt to inflammation
Li, B., & Zheng, S. G. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.65 · Cited by 22
Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis
Comin, F., Speziali, E., Martins‐Filho, O. A., Caldas, I. R., Moura, V., Gazzinelli, A., Corrêa‐Oliveira, R., & Faria, A. M. C. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03403.x · Cited by 22
O'Neill, L. A. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210903 · Cited by 22
The role of T lymphocytes in inflammation.
Ross, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2879 · Cited by 20
Association of TLR4 and TLR5 gene polymorphisms with Graves’ disease in Chinese Cantonese population
Xiao, W., Liu, Z., Lin, J., Xiong, C., Li, J., Wu, K., Ma, Y., Gong, Y., & Liu, Z. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.05.001 · Cited by 20
Köchling, J., Prada, J., Bahrami, M., Stripecke, R., Seeger, K., Henze, G., Wittig, B., & Schmidt, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.094 · Cited by 20
Presence of more activating KIR genes is associated with Hashimoto’s thyroiditis
Ashouri, E., Dabbaghmanesh, M. H., & Omrani, G. R. (2013) · Endocrine · doi:10.1007/s12020-013-0080-2 · Cited by 19
Emerging Role of Uterine Natural Killer Cells in Establishing Pregnancy
Kumar, V., & Medhi, B. (2008) · PubMed · doi:10.22034/iji.2008.48555 · Cited by 18
Characterisation of gamma delta (γδ) T cell populations in patients with sepsis
Galley, H. F., Lowes, D. A., Thompson, K., Wilson, N. D., Wallace, C. A., & Webster, N. R. (2014) · Cell Biology International · doi:10.1002/cbin.10361 · Cited by 18
Cognasse, F., Hamzeh‐Cognasse, H., & Garraud, O. (2008) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2008.07.010 · Cited by 15
Innate Lymphoid Cells: Immunoregulatory Cells of Mucosal Inflammation
Kumar, V. (2014) · European Journal of Inflammation · doi:10.1177/1721727x1401200102 · Cited by 15
Critical role of Toll-like receptor signaling in NK cell activation
Guo, Q., & Zhang, C. (2012) · Chinese Science Bulletin · doi:10.1007/s11434-012-5257-1 · Cited by 14
Rich, T., Allen, R. L., & Trowsdale, J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02026-6 · Cited by 13
Millard, A., Spirig, R., Mueller, N. J., Seebach, J. D., & Rieben, R. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.284 · Cited by 13
Endothelial Cells and Inflammation
Sutton, N. R., Baek, A. E., & Pinsky, D. J. (2014) · Springer eBooks · doi:10.1007/978-0-387-84828-0_184 · Cited by 10
Lei, T., Tang, W., Xiong, Y., Di, Y., Zhang, K., & Shu, X. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.11.007 · Cited by 9
In this issue: Antibodies in pathogenesis and management of diseases
Kumar, H., & Bot, A. I. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1290936 · Cited by 9
Li, J.-T., Guo, C., Li, M., Wei, Y., Hou, Y., Jiao, Y., Zhao, Y., Sun, H. Q., Xu, J., Cao, M., et al. (2016) · Endocrine Practice · doi:10.4158/ep151175.or · Cited by 7
Tokarz, S. A., DeValk, J., Luo, W., Pattnaik, B. R., Schrodi, S. J., & Pillers, D. M. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.04.011 · Cited by 3
TLR4 gene polymorphism associated with lifetime cigarette smoking in bipolar disorder
Zerdazi, E., Oliveira, J., Vorspan, F., Bennabi, M., Jamain, S., Étain, B., Leboyer, M., Tamouza, R., & Bellivier, F. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.01.021 · Cited by 3
Cited by
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023) · Cells · doi:10.3390/cells12010184 · Cited by 889
Kumar, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01722 · Cited by 684
Sameer, A. S., & Nissar, S. (2021) · BioMed Research International · doi:10.1155/2021/1157023 · Cited by 323
Huang, J.-N., Wen, B., Zhu, J.-G., Zhang, Y.-S., Gao, J.-Z., & Chen, Z.-Z. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138929 · Cited by 277
Recent clinical trends in Toll‐like receptor targeting therapeutics
Anwar, M. A., Shah, M., Kim, J., & Choi, S. (2019) · Medicinal Research Reviews · doi:10.1002/med.21553 · Cited by 275
Metadata
- Authors
- Vijay, K.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 59
- Pages
- 391-412
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2800750353
- Cited by
- 643
- References
- 516
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.